FTSE 100
9.866,53
PKT
-4,15
PKT
-0,04
%
Werbung
Analysen zu FTSE 100-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 29.10.14 | Standard Chartered Neutral | Goldman Sachs Group Inc. | |
| 29.10.14 | BP Neutral | Goldman Sachs Group Inc. | |
| 29.10.14 | BP Neutral | UBS AG | |
| 29.10.14 | Lloyds Banking Group buy | UBS AG | |
| 29.10.14 | Standard Chartered buy | UBS AG | |
| 28.10.14 | Standard Chartered Halten | Independent Research GmbH | |
| 28.10.14 | Unilever Neutral | Goldman Sachs Group Inc. | |
| 28.10.14 | Unilever Neutral | Goldman Sachs Group Inc. | |
| 28.10.14 | BP buy | S&P Capital IQ | |
| 28.10.14 | Standard Chartered Hold | S&P Capital IQ | |
| 28.10.14 | International Consolidated Airlines overweight | JP Morgan Chase & Co. | |
| 28.10.14 | GSK Hold | Kepler Cheuvreux | |
| 28.10.14 | London Stock Exchange (LSE) overweight | Morgan Stanley | |
| 28.10.14 | International Consolidated Airlines Neutral | Goldman Sachs Group Inc. | |
| 28.10.14 | Reckitt Benckiser buy | Deutsche Bank AG | |
| 28.10.14 | International Consolidated Airlines buy | Deutsche Bank AG | |
| 28.10.14 | HSBC Hold | Deutsche Bank AG | |
| 27.10.14 | GSK Sell | UBS AG | |
| 27.10.14 | BAT Halten | Independent Research GmbH | |
| 27.10.14 | International Consolidated Airlines overweight | Morgan Stanley | |
| 27.10.14 | Rio Tinto Outperform | BNP PARIBAS | |
| 27.10.14 | AstraZeneca buy | UBS AG | |
| 27.10.14 | Lloyds Banking Group Underperform | Jefferies & Company Inc. | |
| 27.10.14 | BP Neutral | Goldman Sachs Group Inc. | |
| 27.10.14 | Shell (ex Royal Dutch Shell) Neutral | Goldman Sachs Group Inc. | |
| 27.10.14 | Lloyds Banking Group buy | Deutsche Bank AG | |
| 27.10.14 | Barclays buy | Deutsche Bank AG | |
| 24.10.14 | Unilever Equal-Weight | Morgan Stanley | |
| 24.10.14 | GSK Sell | UBS AG | |
| 24.10.14 | Unilever Neutral | UBS AG | |
| 24.10.14 | Barclays buy | UBS AG | |
| 24.10.14 | Lloyds Banking Group buy | UBS AG | |
| 24.10.14 | BP Neutral | UBS AG | |
| 24.10.14 | Shell (ex Royal Dutch Shell) buy | UBS AG | |
| 23.10.14 | GSK Sell | UBS AG | |
| 23.10.14 | GSK neutral | Independent Research GmbH | |
| 23.10.14 | Unilever Sell | S&P Capital IQ | |
| 23.10.14 | Unilever verkaufen | S&P Capital IQ | |
| 23.10.14 | GSK overweight | Morgan Stanley | |
| 23.10.14 | Unilever Underweight | JP Morgan Chase & Co. |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.